metastatic/advanced RCC (mRCC) - (neo)adjuvant(NA) | metastatic/advanced RCC (mRCC) - 1st line (L1) | metastatic/advanced RCC (mRCC) - 2nd line (L2) | |||
metastatic/advanced RCC (mRCC) - (neo)adjuvant(NA) | metastatic/advanced RCC (mRCC) - 1st line (L1) | mRCC - L1 - PDL1 negative | mRCC - L1 - PDL1 positive | metastatic/advanced RCC (mRCC) - 2nd line (L2) | |
atezolizumab based treatment | |||||
atezolizumab alone | IMmotion-150 ... | IMmotion-150 ... | |||
atezolizumab plus bevacizumab | IMmotion-150 ... | IMmotion-150 ... | |||
atezolizumab plus cabozantinib | CONTACT-03 |